Seven Bridges Selected To Build Groundbreaking Data Analysis Platform To Fight Pediatric Disease

August 15, 2017 New data resource center will be created with the NIH and Children’s Hospital of Philadelphia to enable pediatric research across both cancer and structural birth defects datasets for the first time BOSTON, Mass., and PHILADELPHIA, Penn., August 15, 2017 –  Seven Bridges, the biomedical data analysis company, today announced that it has been selected... Read more

Cambridge Epigenetix and NuGEN Technologies sign partnership agreement to combine leading technologies in epigenetics research

Cambridge, UK, Aug 15, 2017 Co-exclusive global licence covers manufacture and integration of CEGX TrueMethyl® technology for oxidative bisulfite sequencing (oxBS-Seq) with Targeted Methylation and NuGEN Ovation Methyl-Seq systems​ Cambridge Epigenetix (CEGX) and NuGEN Technologies, leaders in innovative epigenetic technologies, today announced that they have entered into a partnership agreement to integrate the CEGX TrueMethyl technology for oxidative bisulfite sequencing... Read more

Oxford Instruments to expand Its Asia-Pacific R&D Center at ITRI

09 August 2017 Oxford Instruments plc announced today (August 9) that it intends to increase personnel at its R&D base located at the Industrial Technology Research Institute (ITRI) in Taiwan. It also plans to leverage ITRI’s R&D capacities to strengthen the cooperative relationship in the development of innovative technologies. Y. Tim Tsai, Advisor at the... Read more

Bard Shareholders Approve Proposed Merger With Becton, Dickinson

MURRAY HILL, N.J. and FRANKLIN LAKES, N.J., Aug. 8, 2017 /PRNewswire/ — C. R. Bard, Inc. (NYSE: BCR) (“Bard”) and Becton, Dickinson and Company (NYSE: BDX) (“BD”) today announced the results of Bard’s special meeting of shareholders, held on August 8, 2017 and at which a quorum was present, for Bard shareholders to consider and vote... Read more

Hungarian Ministry of Agriculture Selects Bruker NMR FoodScreener® for Authentication and Identification of Hungarian Wines

BUDAPEST, Hungary, Aug. 8, 2017 /PRNewswire/ — The Hungarian Ministry of Agriculture has selected Bruker’s collaboration partner Diagnosticum to implement a new program to authenticate and identify Hungarian wines. Diagnosticum and Bruker will form the Hungarian Wine Consortium and develop a Hungarian wine model based on Bruker’s NMR FoodScreener technology for rapid and comprehensive wine-profiling.... Read more

Thermo Fisher Extends Cash Tender Offer for All Outstanding Shares of Patheon to Coordinate Offer Timing with Two Remaining Regulatory Approvals

Offer Now Scheduled to Expire at 5:00 p.m., New York City Time, on August 28, 2017 WALTHAM, Mass., Aug. 7, 2017 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that its wholly owned subsidiary, Thermo Fisher (CN) Luxembourg S.à r.l., has extended the offering period of its previously announced all-cash tender offer to... Read more

Bruker Acquires Company XGLab with Unique X-Ray Detection Technologies and XRF Instruments for Art & Conservation Markets

BERLIN, Aug. 7, 2017 /PRNewswire/ — Bruker today announced that it has acquired XGLab S.r.l., a company that develops and manufactures analytical instruments for applications in the field of X-Ray spectrometry and imaging, as well as advanced electronics for X-Ray and Gamma radiation detection.  Financial details of the transaction were not disclosed. Located in Milan, Italy,... Read more

Edico Genome Signs Contracts With NHGRI And NCI For Use Of DRAGEN For Cancer Research

SAN DIEGO, Aug. 2, 2017 — Edico Genome today announced it has signed contracts with the National Human Genome Research Institute (NHGRI) and the National Cancer Institute (NCI) for the use of its DRAGENTM(Dynamic Read Analysis for Genomics) Bio-IT platform. Continuing their initiatives to advance cancer research, NHGRI and NCI purchased Edico Genome’s DRAGEN Somatic pipeline and DRAGEN Genome pipeline, ensuring accuracy, reducing costs... Read more

Bruker Announces Acquisition of Field-Portable Platform for Fast and Universal Immunoassay-Detection of Bacteria, Viruses and Toxins

LEIPZIG, Germany, Aug. 2, 2017 /PRNewswire/ — Bruker today announced the closing of a technology platform and product line acquisition to further expand its range of bacterial, viral and toxin detection solutions for homeland security bio-detection and for selected microbiology applications.  Financial details were not disclosed. The acquired assets include intellectual property, a field-portable, electrochemical chip-based detection... Read more